Summary:
- Bionano Genomics (BNGO, Financial) shares soared by 20% following an earnings announcement alongside a significant 93% price target cut.
- Updated revenue forecasts for 2025 now stand at $30.3 million, with anticipated losses per share declining to $6.00.
- Despite reduced price targets, the momentum suggests an optimistic outlook among analysts.
Bionano Genomics (BNGO) made headlines as its shares experienced a remarkable 20% surge post-earnings. However, this comes in contrast to the significant adjustment made by analysts, who have slashed the stock's price target by 93% to $4.00. On a brighter note, the company revised its revenue projections for 2025 upward to $30.3 million. Additionally, the forecasted losses per share have shrunk substantially to $6.00, indicating a shifting financial sentiment, even as the company is anticipated to underperform when compared to its industry peers.
Wall Street Analysts Forecast
According to the latest analysis by two experts, Bionano Genomics Inc (BNGO, Financial) has an average one-year price target of $7.00. These projections include a high estimate of $10.00 and a low of $4.00, suggesting a potential upside of 88.17% from the current trading price of $3.72. For investors looking to delve deeper, further detailed estimates are available on the Bionano Genomics Inc (BNGO) Forecast page.
The stock's current average brokerage recommendation stands at 2.7, derived from insights by three brokerage firms, which translates to a "Hold" status. The rating system ranges from 1 to 5, with 1 being Strong Buy and 5 being Sell.
Moreover, the estimated GF Value for Bionano Genomics Inc (BNGO, Financial) projects a year-out valuation of $375.09. This represents a staggering potential upside of 9983.06% from the current price of $3.72. The GF Value is GuruFocus' calculated fair value of the stock based on its historical trading multiples, past business growth, and future performance estimates. Comprehensive data and insights are accessible on the Bionano Genomics Inc (BNGO) Summary page.
